Other Viruses Citation List:
April 16 - April 29, 2010
Hepatitis C Virus
1. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.
Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, Fridell RA, Serrano-Wu MH, Langley DR, Sun JH, O'Boyle Ii DR, Lemm JA, Wang C, Knipe JO, Chien C, Colonno RJ, Grasela DM, Meanwell NA, Hamann LG.
Nature. 2010 Apr 21. [Epub ahead of print]PMID: 20410884 [PubMed - as supplied by publisher]
2. Synthesis of 2'-fluoro and 2',4'-dimethyl pyrimidine C-nucleoside analogues as potential anti-HCV agents.
Liu LJ, Hong JH.
Nucleosides Nucleotides Nucleic Acids. 2010 Mar;29(3):216-27.PMID: 20408052 [PubMed - in process]
3. In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses.
Selvam P, Murgesh N, Chandramohan M, De Clercq E, Keyaerts E, Vijgen L, Maes P, Neyts J, Ranst MV.
Indian J Pharm Sci. 2008 Jan;70(1):91-4.PMID: 20390088 [PubMed - in process]
Herpes Simplex Virus
4. Inhibition of HSV-1 Attachment, Entry, and Cell-to-Cell Spread by Functionalized Multivalent Gold Nanoparticles.
Baram-Pinto D, Shukla S, Gedanken A, Sarid R.
Small. 2010 Apr 14. [Epub ahead of print]PMID: 20394070 [PubMed - as supplied by publisher]